You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,001,153


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,001,153
Title: Ocular hypotensive agents
Abstract:The present invention relates to ocular hypotensive agents which contains 13,14-dihydro-15-keto-prostagrandins, which shows no transient ocular hypertensive response that PGs usually show.
Inventor(s): Ueno; Ryuzo (Nishinomiya), Ueno; Ryuji (Nishinomiya), Oda; Tomio (Itami, JP)
Assignee: K.K. Ueno Seiyaku Oyo Kenkyujo (Osaka, JP)
Application Number:07/246,059
Patent Claim Types:
see list of patent claims
Composition; Use; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,001,153: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for anyone involved in intellectual property, whether you are an inventor, a business executive, or an investor. This article will delve into the details of United States Patent 5,001,153, exploring its claims, the patent landscape, and how to gather and analyze relevant information.

What is United States Patent 5,001,153?

United States Patent 5,001,153 pertains to a specific composition, namely "13,14-dihydro-15-keto-20-ethyl-PGF2α isopropyl ester," which is a prostaglandin analog used in medical applications. This patent is significant in the pharmaceutical industry, particularly in the development and use of ophthalmic medications.

Claims of the Patent

Claim Structure

The claims of a patent define the scope of the invention and are critical in determining what is protected under the patent. For U.S. Patent 5,001,153, the claims would typically include:

  • Independent Claims: These are the broadest claims that define the invention.
  • Dependent Claims: These claims are narrower and depend on the independent claims, often adding additional limitations or features.

Claim Analysis

To analyze the claims, one must look at the language and the elements described. For example:

  • Claim 1 might read: "A composition comprising 13,14-dihydro-15-keto-20-ethyl-PGF2α isopropyl ester."
  • Dependent Claims might include specific formulations, methods of use, or additional components that are part of the composition.

Patent Landscape

Prior Art and Patentability

The patentability of U.S. Patent 5,001,153 would have been determined by the patent examiner's review of prior art. This involves assessing whether the claims are novel, non-obvious, and useful in light of existing scientific literature and patents[1].

Competitors and Related Patents

Understanding the patent landscape involves identifying related patents and competitors. For instance, other patents related to prostaglandin analogs or ophthalmic medications could be relevant. Tools like the USPTO's Patent Public Search or the Global Dossier can help in identifying these related patents and their file histories[4].

How to Gather Information

Patent File Wrappers

Patent file wrappers are a valuable resource for gathering competitive intelligence. They contain documents such as cited prior art, applicant amendments, examiner's search strategy, rejections, and notices of allowance. These documents can provide insights into why certain claims were allowed or rejected and what makes the technology unique or not unique in the eyes of the patent office[1].

Public Search Facilities

The USPTO provides several tools and facilities for searching patents, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources can help in finding and analyzing the patent and related documents[4].

Analyzing the Examination Process

Office Actions and Rejections

The examination process for U.S. Patent 5,001,153 would have involved office actions and potential rejections. Analyzing these documents can reveal the arguments made by the examiner and the applicant's responses. This can provide valuable insights into the strengths and weaknesses of the patent claims[1].

Claim Narrowing

During the examination process, the applicant may have narrowed the scope of the claims to overcome rejections. This process can be iterative, with multiple office actions and requests for continued examination until the patent is either allowed or abandoned[1].

Metrics for Measuring Patent Scope

Independent Claim Length and Count

Research has shown that metrics such as independent claim length and count can be useful in measuring patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

International Patent Landscape

Searching International Patent Offices

To understand the global patent landscape, it is essential to search databases from other international intellectual property offices. Resources like the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) provide access to international patent databases[4].

Practical Applications and Implications

Licensing and Litigation

Understanding the scope and claims of U.S. Patent 5,001,153 is crucial for licensing and litigation purposes. It helps in determining the boundaries of what is protected and what can be licensed or challenged.

Investment Decisions

For investors, analyzing the patent landscape and the scope of the claims can be critical in making informed investment decisions. It helps in assessing the potential market impact and the competitive position of the patented technology.

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is essential for determining the scope of the patent.
  • Patent Landscape: Identifying related patents and competitors is crucial for competitive intelligence.
  • File Wrappers: These documents provide valuable insights into the examination process and the uniqueness of the technology.
  • International Search: Searching international patent databases helps in understanding the global patent landscape.
  • Metrics for Patent Scope: Independent claim length and count can be useful metrics for measuring patent scope.

FAQs

Q: What is the significance of the composition claimed in U.S. Patent 5,001,153?

A: The composition, "13,14-dihydro-15-keto-20-ethyl-PGF2α isopropyl ester," is a prostaglandin analog used in ophthalmic medications, making it significant in the pharmaceutical industry.

Q: How can I find related patents to U.S. Patent 5,001,153?

A: You can use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases to find related patents.

Q: What information can be found in a patent file wrapper?

A: A patent file wrapper contains documents such as cited prior art, applicant amendments, examiner's search strategy, rejections, and notices of allowance, which are essential for understanding the patent's uniqueness and the examination process.

Q: Why is it important to analyze the examination process of a patent?

A: Analyzing the examination process helps in understanding the strengths and weaknesses of the patent claims and the arguments made by the examiner and the applicant.

Q: How can metrics like independent claim length and count help in patent analysis?

A: These metrics can help in measuring patent scope and understanding the likelihood of patent grant and the duration of the examination process.

Sources

  1. IP Checkups, "Patent file wrappers as a tool for competitive intelligence," February 5, 2023.
  2. Administrative Conference of the United States, "U.S. Patent Small Claims Court," April 28, 2022.
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.
  4. USPTO, "Search for patents," October 18, 2018.
  5. FDA, "21214 Rescula Administrative Documents," accessed December 19, 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,001,153

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,001,153

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-235890Sep 18, 1987
Japan62-334037Dec 29, 1987

International Family Members for US Patent 5,001,153

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0289349 ⤷  Subscribe 300135 Netherlands ⤷  Subscribe
European Patent Office 0289349 ⤷  Subscribe SPC/GB04/007 United Kingdom ⤷  Subscribe
European Patent Office 0289349 ⤷  Subscribe C300135 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.